Follow
Paola Castagnino
Paola Castagnino
Verified email at pennmedicine.upenn.edu
Title
Cited by
Cited by
Year
Cell-cycle control by physiological matrix elasticity and in vivo tissue stiffening
EA Klein, L Yin, D Kothapalli, P Castagnino, FJ Byfield, T Xu, I Levental, ...
Current biology 19 (18), 1511-1518, 2009
4872009
Smad2 transduces common signals from receptor serine–threonine and tyrosine kinases
MP De Caestecker, WT Parks, CJ Frank, P Castagnino, DP Bottaro, ...
Genes & development 12 (11), 1587-1592, 1998
3661998
Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF‐dependent mitogenic signals.
F Fazioli, L Minichiello, V Matoska, P Castagnino, T Miki, WT Wong, ...
The EMBO journal 12 (10), 3799-3808, 1993
2401993
Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening
D Kothapalli, SL Liu, YH Bae, J Monslow, T Xu, EA Hawthorne, FJ Byfield, ...
Cell reports 2 (5), 1259-1271, 2012
2142012
A protein-binding domain, EH, identified in the receptor tyrosine kinase substrate Eps15 and conserved in evolution.
WT Wong, C Schumacher, AE Salcini, A Romano, P Castagnino, ...
Proceedings of the National Academy of Sciences 92 (21), 9530-9534, 1995
1791995
Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis
RM Day, V Cioce, D Breckenridge, P Castagnino, DP Bottaro
Oncogene 18 (22), 3399-3406, 1999
1111999
ABCG2 expression and side population abundance regulated by a transforming growth factor β–directed epithelial-mesenchymal transition
L Yin, P Castagnino, RK Assoian
Cancer research 68 (3), 800-807, 2008
1032008
Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine-and SH2-independent.
P Castagnino, Z Biesova, WT Wong, F Fazioli, GN Gill, PP Di Fiore
Oncogene 10 (4), 723-729, 1995
891995
Studying the effects of matrix stiffness on cellular function using acrylamide-based hydrogels
A Cretu, P Castagnino, R Assoian
JoVE (Journal of Visualized Experiments), e2089, 2010
882010
Rac-dependent cyclin D1 gene expression regulated by cadherin-and integrin-mediated adhesion
AK Fournier, LE Campbell, P Castagnino, WF Liu, BM Chung, VM Weaver, ...
Journal of cell science 121 (2), 226-233, 2008
852008
A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription
NA Barlev, AV Emelyanov, P Castagnino, P Zegerman, AJ Bannister, ...
Molecular and cellular biology, 2003
822003
Matrix metalloproteinase-12 is an essential mediator of acute and chronic arterial stiffening
SL Liu, YH Bae, C Yu, J Monslow, EA Hawthorne, P Castagnino, ...
Scientific Reports 5 (1), 17189, 2015
692015
Cell adhesion, cellular tension, and cell cycle control
EA Klein, Y Yung, P Castagnino, D Kothapalli, RK Assoian
Methods in enzymology 426, 155-175, 2007
692007
Stiffness-dependent motility and proliferation uncoupled by deletion of CD44
Z Razinia, P Castagnino, T Xu, A Vázquez-Salgado, E Puré, RK Assoian
Scientific Reports 7 (1), 16499, 2017
622017
Cardiovascular protection in females linked to estrogen-dependent inhibition of arterial stiffening and macrophage MMP12
S Liu, A Bajpai, EA Hawthorne, Y Bae, P Castagnino, J Monslow, E Puré, ...
JCI insight 4 (1), 2019
432019
Induction of tissue inhibitor of metalloproteinases-3 is a delayed early cellular response to hepatocyte growth factor
P Castagnino, JV Soriano, R Montesano, DP Bottaro
Oncogene 17 (4), 481-492, 1998
431998
Apolipoprotein E-mediated cell cycle arrest linked to p27 and the Cox2-dependent repression of miR221/222
D Kothapalli, P Castagnino, DJ Rader, MC Phillips, S Lund-Katz, ...
Atherosclerosis 227 (1), 65-71, 2013
332013
Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations
MV Lorenzi, P Castagnino, Q Chen, M Chedid, T Miki
Oncogene 15 (7), 817-826, 1997
321997
YAP1 activation by human papillomavirus E7 promotes basal cell identity in squamous epithelia
J Hatterschide, P Castagnino, HW Kim, SM Sperry, KT Montone, D Basu, ...
Elife 11, e75466, 2022
312022
miR-221/222 compensates for Skp2-mediated p27 degradation and is a primary target of cell cycle regulation by prostacyclin and cAMP
P Castagnino, D Kothapalli, EA Hawthorne, SL Liu, T Xu, S Rao, Y Yung, ...
PLoS One 8 (2), e56140, 2013
312013
The system can't perform the operation now. Try again later.
Articles 1–20